Background Adenoid cystic carcinoma is a rare salivary gland malignancy with a poor disease free survival due to frequent distant metastases and late local recurrences. Previous single-center reports on outcome mostly encompass small series. In this report a relative large series of 105 cases is analyzed, all treated at the VU University Medical Center, Amsterdam, The Netherlands over a 30-year period in which treatment strategies remained unchanged. Methods All cases of ACC of the head and neck between 1979 and 2009 at our institution were analyzed through a medical chart review. Recurrence patterns and possible prognostic factors (T-stage, N-status, age, gender, type of salivary gland involved, histological grade, surgical margins, perine...
International audienceBackground: Adenoid cystic carcinoma (ACC) accounts for 1% of malignant head a...
International audienceBackground: Adenoid cystic carcinoma (ACC) accounts for 1% of malignant head a...
International audienceBackground: Adenoid cystic carcinoma (ACC) accounts for 1% of malignant head a...
Background Adenoid cystic carcinoma is a rare salivary gland malignancy with a poor disease free sur...
Copyright © 2013 Daniel Monteiro et al. This is an open access article distributed under the Creativ...
International audienceOBJECTIVES:To describe the clinical, histological and therapeutic characterist...
International audienceOBJECTIVES:To describe the clinical, histological and therapeutic characterist...
International audienceOBJECTIVES:To describe the clinical, histological and therapeutic characterist...
With an incidence of 3–4.5 cases per million, adenoid cystic carcinoma (ACC) of the head and neck is...
CONTEXT AND OBJECTIVE: Salivary gland tumor management requires long-term follow-up because of tumor...
International audienceBackground: Adenoid cystic carcinoma (ACC) accounts for 1% of malignant head a...
International audienceBackground: Adenoid cystic carcinoma (ACC) accounts for 1% of malignant head a...
International audienceBackground: Adenoid cystic carcinoma (ACC) accounts for 1% of malignant head a...
AIM: To describe outcome and prognostic factors, including the effect of radiotherapy, in a consecut...
International audienceBackground: Adenoid cystic carcinoma (ACC) accounts for 1% of malignant head a...
International audienceBackground: Adenoid cystic carcinoma (ACC) accounts for 1% of malignant head a...
International audienceBackground: Adenoid cystic carcinoma (ACC) accounts for 1% of malignant head a...
International audienceBackground: Adenoid cystic carcinoma (ACC) accounts for 1% of malignant head a...
Background Adenoid cystic carcinoma is a rare salivary gland malignancy with a poor disease free sur...
Copyright © 2013 Daniel Monteiro et al. This is an open access article distributed under the Creativ...
International audienceOBJECTIVES:To describe the clinical, histological and therapeutic characterist...
International audienceOBJECTIVES:To describe the clinical, histological and therapeutic characterist...
International audienceOBJECTIVES:To describe the clinical, histological and therapeutic characterist...
With an incidence of 3–4.5 cases per million, adenoid cystic carcinoma (ACC) of the head and neck is...
CONTEXT AND OBJECTIVE: Salivary gland tumor management requires long-term follow-up because of tumor...
International audienceBackground: Adenoid cystic carcinoma (ACC) accounts for 1% of malignant head a...
International audienceBackground: Adenoid cystic carcinoma (ACC) accounts for 1% of malignant head a...
International audienceBackground: Adenoid cystic carcinoma (ACC) accounts for 1% of malignant head a...
AIM: To describe outcome and prognostic factors, including the effect of radiotherapy, in a consecut...
International audienceBackground: Adenoid cystic carcinoma (ACC) accounts for 1% of malignant head a...
International audienceBackground: Adenoid cystic carcinoma (ACC) accounts for 1% of malignant head a...
International audienceBackground: Adenoid cystic carcinoma (ACC) accounts for 1% of malignant head a...
International audienceBackground: Adenoid cystic carcinoma (ACC) accounts for 1% of malignant head a...